US2006166976A1PendingUtilityA1

Compositions and methods for treating or preventing convulsions or seizures

Assignee: VELA PHARMACEUTICALS INCPriority: May 18, 2001Filed: Mar 24, 2006Published: Jul 27, 2006
Est. expiryMay 18, 2021(expired)· nominal 20-yr term from priority
A61P 9/00A61P 43/00A61P 35/00A61P 31/18A61P 25/28A61P 25/14A61P 25/18A61P 25/02A61P 25/30A61P 25/32A61P 25/08A61P 25/16A61P 13/12A61P 17/02A61K 31/5513A61K 31/551
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to compositions comprising S-tofisopam substantially free of R-tofisopam, and methods for treating or preventing convulsions and/or seizures comprising administration of the composition to subjects in need of treatment therefore. Also provided are compositions and methods for treating or preventing convulsions and/or seizures comprising administering S-tofisopam substantially free of R-tofisopam with another anti-convulsant.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising a therapeutically effective amount of S-tofisopam, a prodrug or a pharmaceutically acceptable salt thereof, substantially free of its R enantiomer, and a pharmaceutically acceptable carrier, wherein the amount of S-tofisopam, prodrug, or a pharmaceutically acceptable salt thereof is from 10 mg to 100 mg.

Join the waitlist — get patent alerts

Track US2006166976A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.